Recent advances in targeted drug delivery for the treatment of glioblastoma
Nanoscale · 2024 · 16 (18) · 8689-8707
DOI: 10.1039/d4nr01056f ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2024. Verfasst von Meng Mao und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health, Harbin Institute of Technology, Harbin, China. qianghe@hit.edu.cn. Hauptthemen laut MEDLINE: Glioblastoma, Blood-Brain Barrier, Brain Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 214 Literaturangaben. Gefördert von: Natural Science Foundation of Heilongjiang Province, Key Research and Development Program of Heilongjiang, National Basic Research Program of China.
Abstract (Originalsprache)
This review has focused on the up-to-date development of targeted drug delivery systems to GBM, with specific emphasis on the utilization of nanorobotic delivery systems for active targeting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Medicine and Health, Harbin Institute of Technology, Harbin, China. qianghe@hit.edu.cn.
Förderung
- Natural Science Foundation of Heilongjiang Province
- Key Research and Development Program of Heilongjiang
- National Basic Research Program of China
- National Natural Science Foundation of China
Zitieren
APA
Mao, M., Wu, Y., & He, Q. (2024). Recent advances in targeted drug delivery for the treatment of glioblastoma. Nanoscale, 16(18), 8689-8707. https://doi.org/10.1039/d4nr01056f
Vancouver
Mao M, Wu Y, He Q. Recent advances in targeted drug delivery for the treatment of glioblastoma. Nanoscale. 2024;16(18):8689-8707. doi:10.1039/d4nr01056f
BibTeX
@article{Mao2024,
author = {Mao, Meng and Wu, Yingjie and He, Qiang},
title = {Recent advances in targeted drug delivery for the treatment of glioblastoma},
journal = {Nanoscale},
year = {2024},
volume = {16},
number = {18},
pages = {8689--8707},
doi = {10.1039/d4nr01056f}
}
EUVIMED